AIMP2 and hematopoietic and lymphoid system neoplasm: To establish smFISH as a subclassification tool in hematologic cancer, we performed RNA-smFISH and quantitated expression ratios of AIMP2-DX2/AIMP2 in six different blood cancer cell lines.